ConductScience.org, home

Paper41007755

Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo.

Bharaj IS and 12 others. Biomedicines, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo. Papers, record 41007755. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007755

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Contemporary and Emerging Therapeutics in Cardiovascular-Kidney-Metabolic (CKM) Syndrome: In Memory of Professor Akira Endo.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-09-30
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bharaj ISInderjeet Singhhttps://orcid.org/0000-0002-7253-3346
2Brar AAjithttps://orcid.org/0000-0002-5317-3357
3Kacheria AAayushi
4Purewal KKaren
5Simister AAustin
6Thirupathy UUmabalanhttps://orcid.org/0000-0002-2227-2803
7Gupta PPalakhttps://orcid.org/0009-0006-9327-7608
8Kahlon JJasraj
9Munaim JJuzer
10Thwe EEEi Ei
11Ibrahim SSamer
12Martinez Vargas VValerie
13Vijayaraghavan KKrishnaswamihttps://orcid.org/0000-0002-0919-9736

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References94

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
139030739Potential kidney protective effects of glucagon-like peptide-1 receptor agonists.Nephrology (Carlton)2024https://conductscience.org/library/papers/39030739PubMed
234329774Hepatic Fat Reduction Due to Resmetirom in Patients With Nonalcoholic Steatohepatitis Is Associated With Improvement of Quality of Life.Clin Gastroenterol Hepatol2022https://conductscience.org/library/papers/34329774PubMed
333107592Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/33107592PubMed
4388061712024 update in heart failure.ESC Heart Fail2025https://conductscience.org/library/papers/38806171PubMed
537793348Effects of Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease: A Systemic Review and Meta-Analysis.Am J Nephrol2024https://conductscience.org/library/papers/37793348PubMed
636273831AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity.Gastroenterology2022https://conductscience.org/library/papers/36273831PubMed
739225278Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.N Engl J Med2024https://conductscience.org/library/papers/39225278PubMed
835713973Non-steroidal mineralocorticoid receptor antagonists in cardiorenal disease.Eur Heart J2022https://conductscience.org/library/papers/35713973PubMed
937364790A multisociety Delphi consensus statement on new fatty liver disease nomenclature.J Hepatol2023https://conductscience.org/library/papers/37364790PubMed
1038301917Association between lipoprotein (a) and risk of heart failure: A systematic review and meta-analysis of Mendelian randomization studies.Curr Probl Cardiol2024https://conductscience.org/library/papers/38301917PubMed
1140316962CVOT summit report 2024: new cardiovascular, kidney, and metabolic outcomes.Cardiovasc Diabetol2025https://conductscience.org/library/papers/40316962PubMed
1234581310ANGPTL3 as therapeutic target.Curr Opin Lipidol2021https://conductscience.org/library/papers/34581310PubMed
1335419980Association of lipoprotein (a) and 1 year prognosis in patients with heart failure with reduced ejection fraction.ESC Heart Fail2022https://conductscience.org/library/papers/35419980PubMed
14353634992022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.Circulation2022https://conductscience.org/library/papers/35363499PubMed
1540383455The role of finerenone in heart failure.Trends Cardiovasc Med2025https://conductscience.org/library/papers/40383455PubMed
1640575425Metabolic-dysfunction associated steatotic liver disease and atrial fibrillation: A review of pathogenesis.World J Cardiol2025https://conductscience.org/library/papers/40575425PubMed
1735624390Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management.Curr Atheroscler Rep2022https://conductscience.org/library/papers/35624390PubMed
1838860394Lipoprotein(a), Oxidized Phospholipids, and Progression to Symptomatic Heart Failure: The CASABLANCA Study.J Am Heart Assoc2024https://conductscience.org/library/papers/38860394PubMed
1938718937A review regarding the article 'Electrocardiographic abnormalities in patients with metabolic dysfunction-associated Steatotic liver disease: A systematic review and meta-analysis.'Curr Probl Cardiol2024https://conductscience.org/library/papers/38718937PubMed
2032981345Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart Association.Circulation2020https://conductscience.org/library/papers/32981345PubMed

See all 94 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn PapersSource
42859730Exerkines in Cardiovascular-Kidney-Metabolic Syndrome: An Integrative Framework for Mechanisms and Therapeutic Implications-A Narrative Review.Rev Cardiovasc Med2026https://conductscience.org/library/papers/42859730PubMed
42837317A machine learning-derived aging index for risk stratification and mortality prediction in cardiovascular-kidney-metabolic syndrome: A retrospective cohort study.PLoS Med2026https://conductscience.org/library/papers/42837317PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
GLP1R2740PubTator's text mininghttps://conductscience.org/library/genes/2740NCBI Gene
IL63569PubTator's text mininghttps://conductscience.org/library/genes/3569NCBI Gene
LPA4018PubTator's text mininghttps://conductscience.org/library/genes/4018NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524NCBI Gene
THRB7068PubTator's text mininghttps://conductscience.org/library/genes/7068NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007755

GET https://conductscience.org/api/papers/v1/41007755/references?page=2